Cargando…

Estimated Cost of Anticancer Therapy Directed by Comprehensive Genomic Profiling in a Single-Center Study

PURPOSE: Comprehensive genomic profiling (CGP) detects several classes of genomic alterations across numerous genes simultaneously and can match more patients with genomically targeted therapies than conventional molecular profiling. The current study estimated the costs of anticancer drugs and over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chawla, Anita, Janku, Filip, Wheler, Jennifer J., Miller, Vincent A., Ryan, Jason, Anhorn, Rachel, Zhou, Zhou, Signorovitch, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2018
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446484/ https://www.ncbi.nlm.nih.gov/pubmed/32913996 http://dx.doi.org/10.1200/PO.18.00074

Ejemplares similares

Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors
por: Wheler, Jennifer J., et al.
Publicado: (2016)

Multiple gene aberrations and breast cancer: lessons from super-responders
por: Wheler, Jennifer J., et al.
Publicado: (2015)

Challenges and perspective of drug repurposing strategies in early phase clinical trials
por: Kato, Shumei, et al.
Publicado: (2015)

Thymoma Patients Treated in a Phase I Clinic at MD Anderson Cancer Center: Responses to mTOR Inhibitors and Molecular Analyses
por: Wheler, Jennifer, et al.
Publicado: (2013)

Estimated Direct Medical Cost of Osteoporosis in Saudi Arabia: A Single-Center Retrospective Cost Analysis
por: Balkhi, Bander, et al.
Publicado: (2021)

A pilot study of temsirolimus and body composition
por: Veasey-Rodrigues, Heloisa, et al.
Publicado: (2013)

Estimated cost of comprehensive syringe service program in the United States
por: Teshale, Eyasu H., et al.
Publicado: (2019)

Estimating the Costs of Implementing Comprehensive Primary Care: A Narrative Review
por: Martsolf, Grant R., et al.
Publicado: (2019)

Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population
por: Wheler, Jennifer, et al.
Publicado: (2013)

Dataset for the estimation of costs for direct contact condenser
por: Liu, Dunyu, et al.
Publicado: (2018)

Characteristics and outcomes for patients with advanced vaginal or vulvar cancer referred to a phase I clinical trials program: the MD Anderson cancer center experience
por: Fu, Siqing, et al.
Publicado: (2015)

Direct Healthcare Costs of Moderate and Severe Work-Related Injuries: Estimates from the National Trauma Center of Qatar
por: Consunji, Rafael J., et al.
Publicado: (2022)

Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil
por: Carvalho, Janaína de Pina, et al.
Publicado: (2021)

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
por: Pascarella, Giacomo, et al.
Publicado: (2019)

Bringing target-matched PI3King from the bench to the clinic
por: Janku, Filip
Publicado: (2013)

KRASness and PIK3CAness in Patients with Advanced Colorectal Cancer: Outcome after Treatment with Early-Phase Trials with Targeted Pathway Inhibitors
por: Garrido-Laguna, Ignacio, et al.
Publicado: (2012)

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden
por: Liang, Winnie S., et al.
Publicado: (2018)

Impact of hidradenitis suppurativa on work loss, indirect costs and income
por: Tzellos, T., et al.
Publicado: (2018)

Direct Healthcare Costs Associated with Oligoarticular Juvenile Idiopathic Arthritis at a Single Center
por: Thakral, Amit, et al.
Publicado: (2020)

Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience
por: Hou, Ming-Mo, et al.
Publicado: (2014)

Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States
por: Collier, Sarah A., et al.
Publicado: (2021)

Clinical characteristics and outcomes of pediatric oncology patients with aggressive biology enrolled in phase I clinical trials designed for adults: The university of Texas MD Anderson cancer center experience
por: Corrales-Medina, Fernando F., et al.
Publicado: (2014)

Estimated cost for cardiovascular disease risk-based management at a primary healthcare center in Nepal
por: Aryal, Anu, et al.
Publicado: (2020)

Anaphylaxis in Poland: the epidemiology and direct costs
por: Jahnz-Rozyk, Karina, et al.
Publicado: (2017)

Estimated direct costs of COVID-19 pandemic high in Turkey, but true costs "undoubtedly higher"
Publicado: (2021)

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience
por: Goldstein, Jennifer B., et al.
Publicado: (2017)

Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States
por: Smith, Andrew F, et al.
Publicado: (2009)

The Direct and Indirect Costs of Breast Cancer in Poland: Estimates for 2017–2019
por: Seweryn, Michal, et al.
Publicado: (2022)

Estimation Of Direct Medical Costs Of Middle East Respiratory Syndrome Coronavirus Infection: A Single-Center Retrospective Chart Review Study
por: AlRuthia, Yazed, et al.
Publicado: (2019)

Liquid Biopsies Using Plasma Exosomal Nucleic Acids
por: Möhrmann, Lino, et al.
Publicado: (2019)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

P53 Mutations in Advanced Cancers: Clinical Characteristics, Outcomes, and Correlation between Progression-Free Survival and Bevacizumab-Containing Therapy
por: Said, Rabih, et al.
Publicado: (2013)

Dual EGFR inhibition in combination with anti-VEGF treatment in colorectal cancer
por: Falchook, Gerald S., et al.
Publicado: (2014)

Estimating Costs of the HIV Comprehensive Intervention Using the Spectrum Model — China, 2015–2019
por: Zhang, Youran, et al.
Publicado: (2022)

Cost-effectiveness and affordability of anticancer treatment in Brazil
por: Aguiar, Pedro Nazareth
Publicado: (2020)

Estimate cost of providing methadone maintenance treatment at a methadone clinic in Nairobi Kenya: direct costs
por: Mogaka, Brenda, et al.
Publicado: (2021)

Comprehensive Review on Betulin as a Potent Anticancer Agent
por: Król, Sylwia Katarzyna, et al.
Publicado: (2015)

Estimating the effect of optimizing anticancer drug vials on medical costs in Japan based on the data from a cancer hospital
por: Matsuo, Koichi, et al.
Publicado: (2020)

Characteristics and survival of patients with advanced cancer and p53 mutations
por: Said, Rabih, et al.
Publicado: (2014)

Estimate of Burden and Direct Healthcare Cost of Infectious Waterborne Disease in the United States
por: DeFlorio-Barker, Stephanie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7vkvogioa8kt2erf146torgv7l